Technology
SlabON®
Technology
is an innovative technology that produces a sheet-type large tissue structure composed only of cells.
Technology creates these structures by molding cells obtained through in vitro culture into a desired shape
and then treating and culturing them with two types of organic polymers used as pharmaceutical excipients.
Technology can be easily applied to various cells, including stem cells. By controlling the interaction of cells and extracellular matrix, large-sized aggregates of cells can be prepared without scaffolds.
While the size of a conventional spheroid is about 150~200㎛ in diameter, a sizable biological tissue structure at the cm level can be produced with Technology. We are continuously conducting research to develop transplantable and clinically effective biological tissue structures.
Akrocell Biosciences plans to advance and utilize Technology to develop advanced biopharmaceuticals
and produce large-sized organoids and artificial organs in the future.
SlabON™ Technology
SlabON™ is an innovative technology that produces a sheet-type large tissue structure composed only of cells.
SlabON™ Technology creates these structures by molding cells obtained through in vitro culture into a desired shape
and then treating and culturing them with two types of organic polymers used as pharmaceutical excipients.
SlabON™ Technology can be easily applied to various cells, including stem cells. By controlling the interaction of cells and extracellular matrix, large-sized aggregates of cells can be prepared without scaffolds.
While the size of a conventional spheroid is about
150~200㎛ in diameter, a sizable biolog ical tissue
structure at the cm level can be produced with
SlabON™ Technology. We are continuously
conducting research to develop transplantable
and clinically effective biological tissue structures.
Akrocell Biosciences plans to advance and utilize SlabON™ Technology to develop advanced biopharmaceuticals and produce large-sized organoids and artificial organs in the future.
akrocell Biosciences, Inc.
CEO : Mr. Andy Byungho Song
Business Registration Number : 340-86-02064
Address : 3F, Open Innovation Bldg., Seoul Biohub, 117-3, Hoegi-ro, Dongdaemun-gu, Seoul 02445, Republic of Korea
TEL : +82 (0)2-2135-3730 ㅣ FAX : +82 (0)70-4369-5154
COPYRIGHT akrocell Biosciences, Inc ALL RIGHT RESERVED.
akrocell Biosciences, Inc. ㅣ CEO : Mr. Andy Byungho Song ㅣ Business Registration Number : 340-86-02064
Address : 3F, Open Innovation Bldg., Seoul Biohub, 117-3, Hoegi-ro, Dongdaemun-gu, Seoul 02445, Republic of Korea
TEL : +82 (0)2-2135-3730 ㅣ FAX : +82 (0)70-4369-5154
COPYRIGHT akrocell Biosciences, Inc. ALL RIGHT RESERVED.